At least two doctors of leronlimab covid patients
Post# of 145754
![](/assets/46931549/no_avatar_available_thumb.jpg)
On today's call, Pourhassan noted the Dr. Reckner may be personally responsible for filling out the mild/moderate trial.
Montefiore is all in on leronlimab as they have opened up alzheimer's to leronlimab.
UCLA has a large group of patients. The trial manager there, Dr. Otto Yang, seems like a very by-the-book type of guy. This is his first clinical trial that he has ever supervised in his life. He is not likely going off the rails.
Between UCLA and Montefiore, thats about 40 of the 70 EINDs right there.
If the other docs are clinicians who do not usually talk to the FDA, then those other docs may have little leverage to do anything.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)